Ausgabe 9/2009
Inhalt (32 Artikel)
Exercise intensity and insulin sensitivity: how low can you go?
J. A. Hawley, M. J. Gibala
Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?
K. Færch, K. Borch-Johnsen, J. J. Holst, A. Vaag
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens, U. Grouven, R. Bender, C. Günster, S. Gutschmidt, G. W. Selke, P. T. Sawicki
Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
J. M. Jonasson, R. Ljung, M. Talbäck, B. Haglund, S. Gudbjörnsdòttir, G. Steineck
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie, C. D. Poole, E. A. M. Gale
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
J. Rosenstock, V. Fonseca, J. B. McGill, M. Riddle, J.-P. Hallé, I. Hramiak, P. Johnston, M. Davis
Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA1c in obese type 2 diabetes patients
D. Hansen, P. Dendale, R. A. M. Jonkers, M. Beelen, R. J. F. Manders, L. Corluy, A. Mullens, J. Berger, R. Meeusen, L. J. C. van Loon
Glucose challenge test screening for prediabetes and undiagnosed diabetes
L. S. Phillips, D. C. Ziemer, P. Kolm, W. S. Weintraub, V. Vaccarino, M. K. Rhee, R. Chatterjee, K. M. V. Narayan, D. D. Koch
Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study
D. G. Bruce, W. A. Davis, G. P. Casey, R. M. Clarnette, S. G. A. Brown, I. G. Jacobs, O. P. Almeida, T. M. E. Davis
Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes
P. Wiesli, P. Krayenbühl, H. Uthoff, B. Seifert, C. Schmid
Familial association between type 1 diabetes and other autoimmune and related diseases
K. Hemminki, X. Li, J. Sundquist, K. Sundquist
Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients
J. Grauslund, A. Green, A. K. Sjølie
Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry
A. Icks, T. Dickhaus, A. Hörmann, M. Heier, G. Giani, B. Kuch, C. Meisinger
Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutrition-related diabetes?
S. Alemu, A. Dessie, E. Seid, E. Bard, P. T. Lee, E. R. Trimble, D. I. W. Phillips, E. H. O. Parry
Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants?
L. Southam, N. Soranzo, S. B. Montgomery, T. M. Frayling, M. I. McCarthy, I. Barroso, E. Zeggini
IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency–low-risk’ variants
E. Morini, S. Prudente, E. Succurro, M. Chandalia, Y.-Y. Zhang, S. Mammarella, F. Pellegrini, C. Powers, V. Proto, B. Dallapiccola, A. Cama, G. Sesti, N. Abate, A. Doria, V. Trischitta
A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis
S. M. Blackman, S. Hsu, S. E. Ritter, K. M. Naughton, F. A. Wright, M. L. Drumm, M. R. Knowles, G. R. Cutting
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
E. Reiling, E. van ’t Riet, M. J. Groenewoud, L. M. C. Welschen, E. C. van Hove, G. Nijpels, J. A. Maassen, J. M. Dekker, L. M. ’t Hart
JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis
S. Abdelli, J. Puyal, C. Bielmann, V. Buchillier, A. Abderrahmani, P. G. H. Clarke, J. S. Beckmann, C. Bonny
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
P. Achenbach, V. Lampasona, U. Landherr, K. Koczwara, S. Krause, H. Grallert, C. Winkler, M. Pflüger, T. Illig, E. Bonifacio, A. G. Ziegler
Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism
S. Fujita, E. L. Glynn, K. L. Timmerman, B. B. Rasmussen, E. Volpi
Microarray analysis of genes with impaired insulin regulation in the skeletal muscle of type 2 diabetic patients indicates the involvement of basic helix-loop-helix domain-containing, class B, 2 protein (BHLHB2)
S. Rome, E. Meugnier, V. Lecomte, V. Berbe, J. Besson, C. Cerutti, S. Pesenti, A. Granjon, E. Disse, K. Clement, E. Lefai, M. Laville, H. Vidal
WNT/β-catenin increases the production of incretins by entero-endocrine cells
J. M. García-Martínez, A. Chocarro-Calvo, C. M. Moya, C. García-Jiménez
Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus
L. Ye, K. O. Lee, L. P. Su, W. C. Toh, H. K. Haider, P. K. Law, W. Zhang, S. P. Chan, E. K. W. Sim
Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies
E. M. Horváth, R. Magenheim, E. Kugler, G. Vácz, A. Szigethy, F. Lévárdi, M. Kollai, C. Szabo, Z. Lacza
Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1
R. Lennon, G. I. Welsh, A. Singh, S. C. Satchell, R. J. Coward, J. M. Tavaré, P. W. Mathieson, M. A. Saleem
Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications
J. Wong, S. V. McLennan, L. Molyneaux, D. Min, S. M. Twigg, D. K. Yue
Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP
M. J. A. van der Plas, M. Baldry, J. T. van Dissel, G. N. Jukema, P. H. Nibbering
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock, V. Fonseca, J. B. McGill, M. Riddle, J. P. Hallé, I. Hramiak, P. Johnston, M. Davis